Effects of Acute Exercise and Allopurinol Administration on Soluble Urokinase Plasminogen Activator Receptor (suPAR)

被引:11
|
作者
Sanchis-Gomar, Fabian [1 ]
Bonaguri, Chiara [2 ]
Pareja-Galeano, Helios [1 ]
Carmen Gomez-Cabrera, Mari [1 ]
Candel, Jorge [3 ]
Vina, Jose [1 ]
Lippi, Giuseppe [2 ]
机构
[1] Univ Valencia, Fdn Invest Hosp Clin Univ, Fac Med, Dept Physiol,INCLIVA, Valencia 46010, Spain
[2] Univ Parma, Azienda Osped, UO Diagnost Ematochim, Dipartimento Patol & Med Lab, I-43100 Parma, Italy
[3] Valencia CF Med Serv, Valencia, Spain
关键词
physical exercise; soluble urokinase plasminogen activator receptor; suPAR; allopurinol; EXHAUSTIVE PHYSICAL-EXERCISE; MORTALITY; TOUR;
D O I
10.7754/Clin.Lab.2012.120728
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Although physical exercise acutely increases the most widely used inflammatory biomarkers, there is no information on its effect on soluble urokinase plasminogen activating receptor (suPAR), a circulating biomarker increasingly used for the assessment of systemic inflammation. Methods: suPAR was assessed with the quantitative suPARnostic (R) Standard ELISA Assay (Virogates, Birkerod, Denmark) in 12 professional football players before and after a football match. The athletes were divided into two experimental groups. An oral dose of 300 mg of allopurinol was administered to one group of six participants four hours before a match; the other six participants received placebo. Results: Serum suPAR concentration did not vary significantly after the match in both the placebo and allopurinol group. No significant differences were observed between placebo and allopurinol groups at baseline and after the game. Conclusions: At variance with other consolidated inflammatory biomarkers, suPAR is not influenced by either physical exercise or administration of xanthine oxidase inhibitors.
引用
收藏
页码:207 / 210
页数:4
相关论文
共 50 条
  • [31] Relationship Between Soluble Urokinase Plasminogen Activator Receptor (suPAR) and Disease Outcome in Adult-Onset Asthma
    Niemela, Taito
    Kankaanranta, Hannu
    Vahatalo, Iida
    Loponen, Juho
    Tuomisto, Leena E.
    Niemela, Onni
    Hamalainen, Mari
    Moilanen, Eeva
    Ilmarinen, Pinja
    JOURNAL OF ASTHMA AND ALLERGY, 2022, 15 : 579 - 593
  • [32] Soluble urokinase-type plasminogen activator receptor (suPAR) and interleukin-6 levels in hyperemesis gravidarum
    Desdicioglu, Raziye
    Yildirim, Melahat
    Kocaoglu, Gulcan
    Cendek, Busra Demir
    Avcioglu, Gamze
    Tas, Emre Erdem
    Sengul, Ozlem
    Erel, Ozcan
    Yavuz, Ayse Filiz
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2018, 81 (09) : 825 - 829
  • [33] Plasma-soluble urokinase plasminogen activator receptor (suPAR) levels in psoriasis patients and correlation with disease severity
    Kurtipek, Gulcan Saylam
    Kesli, Recep
    Akyurek, Fatma Tuncez
    Akyuret, Fikret
    Terzi, Yuksel
    ACTA DERMATOVENEROLOGICA ALPINA PANNONICA ET ADRIATICA, 2015, 24 (04): : 73 - 75
  • [34] Evaluation of soluble urokinase-type plasminogen activator receptor (suPAR) quick test for triage in the emergency department
    Kumar, Pratyush
    Kakar, Atul
    Gogia, Atul
    Waziri, NIamatullah
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2019, 8 (12) : 3871 - 3875
  • [35] Soluble urokinase Plasminogen Activator Receptor (suPAR) levels are predictive of COVID-19 severity: an Italian experience
    Infantino, Maria
    Morena, Lorenza
    Pietro, Massimo Antonio Di
    Romanin, Benedetta
    Cimolato, Barbara
    Rocca, Beatrice Anna Luisa
    Tunnera, Silvia
    Modi, Giulia
    Tilli, Marta
    Grossi, Valentina
    Lari, Barbara
    Cerutti, Helena
    Tesi, Giulia
    Anro, Valentina
    Cartocci, Alessandra
    Benucci, Maurizio
    Veneziani, Francesca
    Casprini, Patrizia
    Manfredi, Mariangela
    CLINICAL IMMUNOLOGY, 2022, 242
  • [36] Relationship of Circulating Soluble Urokinase Plasminogen Activator Receptor (suPAR) Levels to Disease Control in Asthma and Asthmatic Pregnancy
    Ivancso, Istvan
    Toldi, Gergely
    Bohacs, Aniko
    Eszes, Noemi
    Mueller, Veronika
    Rigo, Janos, Jr.
    Vasarhelyi, Barna
    Losonczy, Gyoergy
    Tamasi, Lilla
    PLOS ONE, 2013, 8 (04):
  • [37] Soluble Urokinase Plasminogen Activator Receptor (suPAR) and All-Cause and Cardiovascular Mortality in Diverse Hemodialysis Patients
    Torino, Claudia
    Pizzini, Patrizia
    Cutrupi, Sebastiano
    Postorino, Maurizio
    Tripepi, Giovanni
    Mallamaci, Francesca
    Reiser, Jochen
    Zoccali, Carmine
    KIDNEY INTERNATIONAL REPORTS, 2018, 3 (05): : 1100 - 1109
  • [38] Soluble Urokinase Plasminogen Activator Receptor for Risk Prediction in Patients Admitted with Acute Chest Pain
    Lyngbaek, Stig
    Andersson, Charlotte
    Marott, Jacob L.
    Moller, Daniel V.
    Christiansen, Michael
    Iversen, Kasper K.
    Clemmensen, Peter
    Eugen-Olsen, Jesper
    Hansen, Peter R.
    Jeppesen, Jorgen L.
    CLINICAL CHEMISTRY, 2013, 59 (11) : 1621 - 1629
  • [39] Soluble urokinase plasminogen activator receptor level in individuals of advanced age
    Wlazel, Rafal N.
    Szwabe, Katarzyna
    Guligowska, Agnieszka
    Kostka, Tomasz
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [40] Soluble urokinase plasminogen activator receptor and survival in elective cardiac surgery
    Koller, Lorenz
    Steinacher, Eva
    Hofer, Felix
    Hammer, Andreas
    Kazem, Niema
    Laufer, Guenther
    Fleck, Tatjana
    Steinlechner, Barbara
    Wojta, Johann
    Richter, Bernhard
    Hengstenberg, Christian
    Sulzgruber, Patrick
    Niessner, Alexander
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2023, 53 (05)